Residents of West Virginia might want to learn more about NDMA, a product found in Zantac that has not yet been recalled despite some evidence that it might heighten a person’s cancer risk. The medicine, taken for stomach acid reduction, contains ranitidine.
Ranitidine medicines contain NDMA at low levels. According to the Environmental Protection Agency, NDMA is a chemical found in both industrial and natural processes. It is classified as a probable carcinogen, a cancer-causing chemical. It has been shown to increase cancer risk in animals although there is not consistent evidence how it affects humans.
NDMA also affects the environment. Universities are now focusing on the potential sources of NDMA as levels of this substance in wastewater are rising. Common blood pressure medicines were found to contain this substance and were recalled in certain lots.
The online pharmacy company Valisure destroyed products containing ranitidine and mentioned the idea that the NDMA was the result of the formulation of the ranitidine molecule, which they think might break down when it is digested in the human body. This process creates NDMA.
In the United States, Zantac maker Sanofi has not halted sales. On the other hand, Sandoz, which distributes a generic form, has instituted a recall.
Mass tort litigation happens when a company fails to fulfill its legal obligation to bring a product to the market that is safe. Individual claims from multiple plaintiffs may be pursued separately, or they might be combined. An attorney versed in this type of law may be able to help someone who has been affected by NDMA. The attorney might help clients understand the complexities and complications of medical issues from consumers who are put at risk.
